Email
LumiNUS
Staff
Student
Sharepoint
Home
About Us
Welcome
Head’s Message
Vision and Mission
Our History
Study
Undergraduate (UG)
Postgraduate (PG)
Continuing Education
Research
Research
DERC
Department Research Committee
Seminar Programmes
Research Highlights
People
Leadership Team
Tenure Track Faculty
Educator & Practice Track Faculty
Adjunct and Visiting Faculty
Research Staff
Non-Academic Staff
Career Opportunities
Alumni
PharmConnect Newsletter
Alumni Features
Commencements
Giving
GEA-NUS
Research Highlights
Latest Research Highlights
24
Jul
Congratulations to Assistant Professor Tian Chong who is part of a team of researchers known as the Molecular Ratcheteers, on being awarded the Organic Chemistry Horizon Prize: Perkin Prize in Physical Organic Chemistry (2023).
Read More
04
Jul
A NUS start-up, PharLyfe+, founded by A/Prof Chan Sui Yung and her students, Dr Tan Poh Leng and Ms Chua Qi Shan recently developed easy-to-use oral films that enable painless, efficient, and discreet drug administration, especially for young children or the elderly.
Read More
08
May
A/Prof Chan Sui Yung together with Ms Tan Poh Leng (PhD student) and Ms Chua Qi Shan (final-year Pharmacy student) have developed medicated films, a painless and effective way to administer medications. This innovative solution is created by their very own start-up company focusing on drug delivery, Phar-Lyfe+.
Read More
30
Apr
Wonders of Pharmacy: The power of bioinformatics
Read More
10
Apr
Associate Professors Rachel Ee and Rajamani Lakshminarayanan led their research team to develop ‘nanonets’ that can trap and kill bacteria strains to tackle the problem of antibiotic resistance.
Read More
05
Dec
A research team led by Prof Eric Chan has collaborated with the Analytical Toxicology Laboratory of Singapore’s Health Sciences Authority (HSA) to investigate the key metabolic properties and identify urinary biomarkers of four OXIZID analogues, specifically BZO-HEXOXIZID, BZO-POXIZID, 5F-BZO-POXIZID and BZO-CHMOXIZID.
Read More
19
Jul
Congrats to Professor Eric Chan on the latest development of an improved pharmaceutical drug for the treatment of atrial fibrillation (AF) and it took a 8-member research team 8 years to achieve this breakthrough.
Read More
05
Jul
Prof Eric Chan and his team developed a virtual simulation strategy using physiologically-based pharmacokinetic (PBPK) modelling to evaluate the pharmacotherapy of two COVID-19 drugs, Paxlovid and baricitinib. They hope to help guide dose adjustments for those in the vulnerable population.
Read More
02
Jun
Congratulations to Associate Professor Doreen Tan, who has published a few articles with her collaborators!
Read More
Loading...
More
×